1.
Dönmez Çakıl Y, Akbulut Z, Demirel G, Gülhan R, Ozunal Z. The effects of low-dose sorafenib on epithelial-mesenchymal transition and multidrug resistance markers in HepG2 cell line. Eur Res J [Internet]. 2023 Mar. 3 [cited 2026 Apr. 5];9(2):367-74. Available from: https://eurj.org.tr/article/view/735